For the quarter ended January 2025, HealthEquity (HQY) reported revenue of $311.82 million, up 18.8% over the same period last year. EPS came in at $0.69, compared to $0.63 in the year-ago quarter.

So far this year, the Zacks Rank #3 (Hold) stock has gained 43% against ... businesses and harm its financial performance. Stiff Competition: HealthEquity faces stiff competition in the rapidly ...

These ratings convey the analysts' expectations for the relative performance of HealthEquity compared to the broader market. Price Targets: Analysts set price targets as an estimate of a stock's ...

HealthEquity (HQY) stock dropped over 13% aftermarket trading following ... Healthequity’s strong fundamentals and earnings performance, coupled with the pro-HSA political landscape, bolster her ...

Despite its strong performance, HealthEquity faces several challenges ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Analysts on Wall Street project that HealthEquity (HQY ... role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value, with ...

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid third-quarter fiscal 2025 performance ... highlights the one stock set to climb highest.

HealthEquity Inc provides solutions that ... Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently ...

Despite its strong performance, HealthEquity faces several challenges and risks that ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer ...